Han-Jong Kim Selected Research

Han-Jong Kim Research Topics

Disease

3	Vascular Calcification 01/2016 - 02/2012
3	Atherosclerosis 11/2015 - 04/2009
3	Hyperplasia 01/2014 - 10/2009
3	Vascular System Injuries 01/2014 - 04/2009
3	Neoplasms (Cancer) 01/2013 - 03/2007
2	Mitochondrial Diseases (Mitochondrial Disease) 11/2015 - 02/2012
2	Fibrosis (Cirrhosis) 02/2012 - 01/2012
1	Wounds and Injuries (Trauma) 12/2018
1	Vascular Remodeling 01/2014
1	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2014
1	Vascular Diseases (Vascular Disease) 01/2014
1	Neonatal Jaundice 01/2013
1	Prostatic Neoplasms (Prostate Cancer) 01/2013
1	Ureteral Obstruction 01/2012
1	Type 2 Diabetes Mellitus (MODY) 11/2010
1	Insulin Resistance 11/2010
1	Thrombosis (Thrombus) 11/2010
1	Infections 11/2010
1	Hepatocellular Carcinoma (Hepatoma) 02/2010
1	Nephrogenic Diabetes Insipidus 01/2009
1	Carcinogenesis 10/2008
1	Breast Neoplasms (Breast Cancer) 12/2006
1	Body Weight (Weight, Body) 07/2004
1	Familial Hypoadrenocorticism 05/2004
1	Dosage-sensitive sex reversal 05/2004

Drug/Important Bio-Agent (IBA)

2	pyruvate dehydrogenase kinase 4IBA 01/2016 - 11/2015
2	Phosphates (Orthophosphate)IBA 11/2015 - 02/2012
2	Oxidoreductases (Dehydrogenase)IBA 01/2014 - 04/2009
2	Dimethyl FumarateIBA 01/2014 - 01/2012
2	quinone (benzoquinone)IBA 01/2014 - 04/2009
2	Proteins (Proteins, Gene)FDA Link 01/2014 - 11/2010
2	STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA 01/2013 - 10/2008
2	Thioctic Acid (Lipoic Acid)IBA 02/2012 - 11/2010
2	AntioxidantsIBA 02/2012 - 11/2010
2	Collagen Type I (Type I Collagen)IBA 02/2012 - 01/2012
2	Transforming Growth Factors (Transforming Growth Factor)IBA 02/2012 - 01/2012
2	DNA (Deoxyribonucleic Acid)IBA 11/2010 - 12/2006
2	Messenger RNA (mRNA)IBA 11/2010 - 02/2010
2	Estrogen Receptor alphaIBA 03/2007 - 12/2006
1	Interleukin-6 (Interleukin 6)IBA 12/2018
1	Interleukin-10 (Interleukin 10)IBA 12/2018
1	CytokinesIBA 12/2018
1	CollagenIBA 12/2018
1	Pyruvate Dehydrogenase Complex (Dehydrogenase Complex, Pyruvate)IBA 11/2015
1	CalciumIBA 11/2015
1	Pharmaceutical PreparationsIBA 01/2014
1	NF-E2-Related Factor 2IBA 01/2014
1	AgarIBA 01/2013
1	scoparoneIBA 01/2013
1	Cytochromes c (Cytochrome c)IBA 02/2012
1	sulforaphaneIBA 02/2012
1	Caspase 9IBA 02/2012
1	Adenosine Triphosphate (ATP)IBA 02/2012
1	Reactive Oxygen Species (Oxygen Radicals)IBA 02/2012
1	Fibronectins (Fibronectin)IBA 01/2012
1	Glucose (Dextrose)FDA LinkGeneric 11/2010
1	Selenoprotein PIBA 11/2010
1	p38 Mitogen-Activated Protein KinasesIBA 11/2010
1	RNA (Ribonucleic Acid)IBA 11/2010
1	TunicamycinIBA 02/2010
1	ColforsinIBA 02/2010
1	ThapsigarginIBA 02/2010
1	ClusterinIBA 10/2009
1	PyransIBA 04/2009
1	NAD (NADH)IBA 04/2009
1	Antineoplastic Agents (Antineoplastics)IBA 04/2009
1	beta-lapachoneIBA 04/2009
1	Aquaporin 2IBA 01/2009
1	Vasopressins (Vasopressin)IBA 01/2009
1	Serine (L-Serine)FDA Link 10/2008
1	Tyrosine (L-Tyrosine)FDA Link 10/2008
1	cyclopentenoneIBA 03/2007
1	PPAR gammaIBA 03/2007
1	Estrogen ReceptorsIBA 12/2006
1	LigandsIBA 12/2006
1	DisulfidesIBA 12/2006
1	Tamoxifen FDA LinkGeneric 12/2006
1	5- ((4- (4- (diethylamino)butyl)- 1- piperidinyl)acetyl)- 10,11- dihydrobenzo(b,e)(1,4)diazepine- 11- oneIBA 12/2006
1	benzamideIBA 12/2006
1	NucleotidesIBA 07/2004
1	Orphan Nuclear ReceptorsIBA 05/2004
1	Amino Acids FDA Link 05/2004

Therapy/Procedure

2	Therapeutics 04/2009 - 12/2006
1	Ligation 02/2012
1	Drug-Eluting Stents 11/2010
1	Stents 11/2010